ROKIT HEALTHCARE’s Post

Granulox® is a topical haemoglobin spray with proven benefits, that by means of diffusion provides oxygen to wounds with poor blood supply. It transports oxygen from the surrounding air down to the wound bed to accelerate the healing process. Studies report that using Granulox® results in shorter healing time, reduced pain scores and total cost savings for healthcare providers compared to standard of care.** Find out more about Granulox® here: https://bit.ly/3tqMSbQ Reference: *Hunt, SD. Elg, F. Clinical effectiveness of hemoglobin spray (Granulox) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabetic Foot & Ankle. 2016; 7(1):33101. https://lnkd.in/dkmcxGz7. v7.33101. ** Dissemont J, Kröger K, Storck M, Risse A, Engels P. Topical oxygen wound therapies for chronic wounds: a review. Journal of Wound Care, 2015, Feb, 24(2);53-63. #molnlyckemea #granulox #hemoglobin #homecare #education #woundcare

🌟Exciting Developments in Advanced Wound Care🌟 Organogenesis Congrats on this significant regulatory win "Data shows that this will likely lead to a 15-25% increase in product adoption." Considering Medicare's base and the high prevalence of diabetic foot ulcers and venous leg ulcers in the elderly population this is a positive step for patient care, and the expansion of skin substitute graft utilization, which will lead to better outcomes.

Elevate your practice with OxIA screenings. Are you a healthcare provider looking to improve diabetic care? Offer your patients advanced diabetic retinopathy screenings with OxIA technology. This Diabetic Awareness Month, we’re inviting you to join us in offering cutting edge screenings. Learn more: 📧 corporates@oxia.org 📲0824990397 #OxIA #DiabeticAwarenessMonth #DiabeticRetinopathy #EarlyScreening #EarlyDetection #PreventiveHealthCare

🚨 New Publication Alert! 🚨 📄 Title: A Prospective Study to Evaluate Efficacy and Safety of Autologous Platelet-Rich Fibrin Matrix for the Treatment of Chronic Diabetic Foot Ulcers 🔬 Summary: This study explores the use of Autologous Platelet-Rich Fibrin (PRF) Matrix as a potential treatment for chronic diabetic foot ulcers, assessing both its efficacy and safety. With diabetes being a major cause of non-healing foot ulcers, the findings from this study could have significant implications for improving wound healing and preventing complications. 🩺 Key Findings: PRF matrix demonstrated promising results in improving healing outcomes. A safe and minimally invasive alternative to conventional treatments. Potential for widespread clinical adoption in managing diabetic foot complications. 🔗 Read the full study: https://lnkd.in/ghVb_mSY 💬 Join the discussion! What are your thoughts on using PRF in diabetic foot care? Drop your comments below! If you are interested in submitting your manuscript, please let us know. For more Explore: https://lnkd.in/gGf7DCbd Submission link: https://lnkd.in/eBxmp5gE (Select to regular issue) #MedicalResearch #DiabeticFootUlcers #PlateletRichFibrin #FootCare #ChronicWounds #DiabetesManagement #ClinicalResearch #FootAndAnkle

Chronic hand eczema (CHE) is a debilitating dermatosis with limited approved therapies. Learn more here about how to assess and manage patients with CHE: http://ms.spr.ly/6189mmV2R #IEC #internationaleczema #eczemacouncil #atopicdermatitis #eczema

#snsinstitution #snsdesignthinking #snsdesignthinker Myocardial ischemia is a lack of blood flow getting to your heart muscle. That means your heart muscle isn’t getting enough blood to do what it needs to do. Often, the cause is a collection of fat and cholesterol (plaque) that doesn’t let enough blood go through your coronary arteries. Medicines and surgeries can treat myocardial ischemia. Your healthcare provider may recommend medications or lifestyle changes to reduce your risk of myocardial ischemia. Medicines Taking a baby aspirin (or another dose your provider suggests for you) every day to prevent a heart attack. People who can’t take aspirin can take clopidogrel. Beta-blockers.

𝐍𝐞𝐠𝐚𝐭𝐢𝐯𝐞 𝐏𝐫𝐞𝐬𝐬𝐮𝐫𝐞 𝐖𝐨𝐮𝐧𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 (𝐍𝐏𝐖𝐓): 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬 🩺🏥🔬 A Complete Guide of " 𝐍𝐞𝐠𝐚𝐭𝐢𝐯𝐞 𝐏𝐫𝐞𝐬𝐬𝐮𝐫𝐞 𝐖𝐨𝐮𝐧𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 (𝐍𝐏𝐖𝐓) " [ PDF Guide] 𝐆𝐞𝐭 𝐏𝐃𝐅 𝐓𝐨 𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 @ https://lnkd.in/dTGsMuGP Negative pressure wound therapy (NPWT) is a technique used to stimulate wound healing. It involves applying controlled negative pressure to the wound site using a specialized dressing and suction device. This technique is usually used to treat and manage complex or chronic wounds. It has several benefits, such as improved wound healing, removal of excess wound fluid, protection against external contaminants, and pain alleviation.  NPWT is commonly used to manage wounds such as diabetic foot ulcers, venous leg ulcers, surgical wounds, skin grafts, and burn wounds. ◙ 𝐁𝐲 𝐖𝐨𝐮𝐧𝐝 𝐓𝐲𝐩𝐞: ➤ Surgical Wounds ➤ Skin Grafts ➤ Burn Wounds ➤ Other Wound Types ◙ 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: ➤Increasing Prevalence of Diabetes and Chronic Wounds ➤Rising Elderly Population ➤Favorable Reimbursement Policies ➤Increasing Incidence of Obesity and Associated Comorbidities ◙ 𝐁𝐞𝐧𝐢𝐟𝐢𝐭𝐬: ➤ Accelerated Healing ➤Infection Control ➤Improved Circulation ➤Reduced Complications ➤Enhanced Patient Comfort 🔑𝐊𝐞𝐲𝐩𝐥𝐚𝐲𝐞𝐫𝐬: Acelity L.P. Inc. (U.S.), Cardinal Health, Inc. (U.S.), Convatec Group plc (U.S.), DeRoyal Industries, Inc. (U.S.), Genadyne Biotechnologies, Inc. (U.S.), Medela AG (Switzerland), Mölnlycke Health Care AB (Sweden), Smith & Nephew plc (U.K.), PAUL HARTMANN AG (Germany), and Talley Group Ltd (U.K.). #NPWT #WoundHealing #HealthcareInnovation #MedicalTechnology #WoundCare #HealingJourney #PatientRecovery #AdvancedTherapy #MedicalDevices #SurgicalCare #HealthTech #InfectionControl #TissueRegeneration #ClinicalTreatment #WoundManagement #HealthcareAdvancements #TherapeuticSolutions #ChronicWounds #SurgicalRecovery 

𝗔 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐖𝐨𝐮𝐧𝐝 𝐂𝐚𝐫𝐞 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 @ https://lnkd.in/drCB_Z7P The Wound Care Device Market, valued at USD 2.61 billion in 2023, is anticipated to reach USD 3.78 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031. The global wound care device market is experiencing steady growth due to factors such as the increasing prevalence of chronic wounds, rising geriatric population, and advancements in technology. Wound care devices play a crucial role in the management and treatment of various types of wounds, including diabetic ulcers, pressure ulcers, surgical wounds, and burns. The market offers a wide range of products such as dressings, bandages, therapy devices, and negative pressure wound therapy systems that help in promoting healing and preventing infection. Additionally, the introduction of innovative technologies like bioactive wound care products and smart dressings has further propelled the market growth. With the ongoing research and development activities focused on improving existing products and developing novel solutions for wound management, the outlook for the wound care device market remains positive in the coming years. 𝐓𝐡𝐞 𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 → Cardinal Health,  → Smith+Nephew, → Medela,  → 3M, → BSN medical,  → TALLEY GROUP LIMITED,  → Devon Medical Products, → Convatec I, → DeRoyal Industries, Inc.  → and other players. #WoundCare #MedicalDevices #HealthcareInnovation #MarketGrowth #WoundCareTechnology #HealthcareMarket #CAGR #MedicalAdvancements #HealthTech #MarketTrends #2024to2031 #MedicalInnovation #IndustryGrowth #WoundManagement #HealthcareIndustry

Visit us next week at the annual Royal College of Podiatry conference in Harrogate! At booth 74 you can learn more about only multi-modality Topical Wound Oxygen (TWO2) therapy proven 6X more likely to Heal DFUs at 12 weeks, resulting in a 6X lower recurrence at 12 months. (1) With our UK partner G&N, you can learn about the next generation of NPWT: the NEXA™ NPWT System. We look forward to seeing you! #aotinc #two2heals #podiatry 1 Frykberg R, Franks P, et al. A multinational, multicenter, randomized, double-blinded, placebo-controlled trial to evaluate the efficacy of cyclical Topical Wound Oxygen (TWO2) therapy in the treatment of chronic diabetic foot ulcers: the TWO2 study. Diabetes Care, 2020.